Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Almeda Ventures Limited Partnership, established in Tel Aviv, Israel, in 2020, functions as a venture capital firm. The partnership strategically deploys capital across various development stages, including seed, startup, early-stage, and established middle-market companies. Its core investment thesis centers on health technology innovation, with a particular emphasis on medical devices, digital health solutions, bio-convergence, and public R&D collaborations. Additionally, Almeda Ventures allocates funds to life sciences research and development enterprises. Geographically, the firm primarily focuses its investments within Israel, the United States, and Europe.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap'